B4GALNT1

gene product
beta1-4GalNAc-T, GALGT, SPG26
GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. GalNAc-T catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2013]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
167 antibodies from 24 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
2 antibodies
Novus Biologicals
5 antibodies
LifeSpan BioSciences, Inc.
39 antibodies
Abnova Corporation
5 antibodies
antibodies-online
39 antibodies
Invitrogen Antibodies
3 antibodies
NovoPro Bioscience Inc.
3 antibodies
Abgent
1 antibody
Affinity Biosciences
1 antibody
Biorbyt
8 antibodies
Aviva Systems Biology
4 antibodies
Proteintech Group
1 antibody
BioLegend
7 antibodies
GeneTex
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
OriGene
1 antibody
Creative Biolabs
3 antibodies
Boster Biological Technology
2 antibodies
St John's Laboratory
2 antibodies
ProSci
1 antibody
MyBioSource
4 antibodies
Sigma-Aldrich
4 antibodies
Creative Diagnostics
3 antibodies
United States Biological
26 antibodies